Cargando…
Triggering atrial fibrillation after omalizumab injection in a patient with chronic spontaneous urticarial. A case report
INTRODUCTION: Omalizumab is recommended as a third-line treatment in the treatment of chronic spontaneous urticaria. During omalizumab use, which has high efficacy and safety, the side effects observed are usually moderate and temporary. Here we discuss the triggering of atrial fibrillation followin...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448490/ https://www.ncbi.nlm.nih.gov/pubmed/30957094 http://dx.doi.org/10.15386/cjmed-1082 |